Cows for this study come from a larger experiment which evaluated the metabolic effects of postpartum anti-inflammatory treatment (meloxicam) in clinically healthy dairy cows. In the underlying study, 20 out of 42 Holstein cows received subcutaneous injections of meloxicam (0.5 mg/kg of body weight; Metacam, Boehringer Ingelheim Canada Ltd., Burlington, ON, Canada) once daily on 10, 11, 12 and 13 DIM. For the present study, 21 cows were retrospectively and deliberately selected to balance as nearly as possible for meloxicam treatment (n = 9 were treated with meloxicam and n = 12 were non-treated control), parity, and uterine health status (described below). Meloxicam treatment did not affect the uterine inflammatory status19 nor the uterine microbiome composition20. This lack of effect allowed us to study the associations between reproductive tract inflammatory disease and the uterine microbiome in the postpartum period.
Cows were managed according to the guidelines set by the National Farm Animal Care Council. Animal handling procedures and sampling were approved by the University of Guelph Animal Care Committee (Animal Utilization Protocol 3852). Sampling was conducted from April to August 2018 at the University of Guelph Livestock Research and Innovation Centre, Dairy Facility (Elora, ON, Canada). Briefly, pregnant dry cows were housed in free-stall barns and moved to individual calving pens when showing signs of imminent calving (e.g., swelling of the vulva and relaxation of the pelvic ligaments) or 48 h before expected calving. Five days after calving, cows were moved to a free-stall lactating pen, where they remained until the end of the experiment (35 DIM). Cows were fed for ad libitum intake and diet data are reported in Pascottini et al.19. Milking was done twice daily in a rotary parlour. Only cows considered clinically healthy having unassisted calving, and no retained placenta, metritis, or other clinical disease before or during the study period were included in the present analysis. None of the cows were treated with antibiotics from calving to 35 DIM (locally or systemically).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.